Pegvisomant
Somavert (pegvisomant) is a protein pharmaceutical. Pegvisomant was first approved as Somavert on 2002-11-12. It is used to treat acromegaly in the USA. It has been approved in Europe to treat acromegaly. The pharmaceutical is active against growth hormone receptor.
| Trade Name | Somavert |
|---|---|
| Common Name | Pegvisomant |
| Indication | acromegaly |
| Drug Class | Pegylated compounds |
